I am a pharmaceutical researcher with a focus on computational drug discovery. My work involves using computer-based methods to identify and evaluate potential drug candidates. I have published two peer-reviewed research papers where I worked on problems such as diabetic nephropathy and lung cancer, using techniques like molecular docking, molecular dynamics simulations, and drug repurposing strategies.
I enjoy applying research skills to real-world problems and am particularly interested in industry-focused drug discovery, where science, data, and practical impact come together. This website showcases my research work and technical skills.
Discovered potential non-glycosidic SGLT2 inhibitor leads by using an integrated computational workflow involving pharmacophore modeling, virtual screening, molecular docking, and molecular dynamics simulations.
Evaluated FDA-approved antimalarial drugs as multi-target candidates for non-small cell lung cancer using molecular docking, molecular dynamics simulations, and in vitro anticancer assays.